Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Charcot-Marie-Tooth Disease

1,2,3,4-tetrahydroquinoline has been researched along with Charcot-Marie-Tooth Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bařinka, C; Benoy, V; Kozikowski, AP; Kutil, Z; Langley, B; Pavlíček, J; Picci, C; Robers, MB; Shen, S; Tavares, MT; Ustinova, K; Van Den Bosch, L; Zhang, G; Zimprich, CA1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Charcot-Marie-Tooth Disease

ArticleYear
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.
    Journal of medicinal chemistry, 2021, 04-22, Volume: 64, Issue:8

    Topics: Acetylation; Animals; Benzamides; Binding Sites; Charcot-Marie-Tooth Disease; Crystallography, X-Ray; Disease Models, Animal; Half-Life; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Phenotype; Protein Isoforms; Quinolines; Structure-Activity Relationship; Tubulin

2021